Latest filing published 04 Nov 2026 for Regeneron Pharmaceuticals, INC., €156k.
Insider track record
No signal scores available.
Jason Pitofsky: trading record in brief
This profile gathers the share dealings of Jason Pitofsky in Regeneron Pharmaceuticals, Inc. In total, 2 filings cover trades dated 4 November 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 4 November 2026, reports a transaction of €156k in Regeneron Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jason Pitofsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 180 shares@ US$973.36Common StockSEC144:0001968582-26-001101
- 3,883 shares@ US$976.00Common stockSEC144:0001969223-26-001125
2 of 2 declarations
